INS and type 2 diabetes mellitus: The improvements in the GLUPeak and GLUP-N suggest that, compared to the SM, the MM produces a more favorable postprandial insulin response for both healthy and T2D individuals, which is confirmed by the overall 2.6-fold reduction in insulin responses at 60 min following the MM consumption.